Dr Albert Goh_sydneymedicalintervetions_

Our passion for arteries leads us to an exciting research trial

As our insatiable quest for knowledge and the passion to help people continues to grow, director of Sydney Medical Interventions, Dr Albert Goh is excited to be the principal investigator at the RNSH for the SHIELD Clinical Trial (Study in Humans to Investigate the Efficacy and Safety of Luminal SBCV Delivery in Peripheral Artery Disease). As a consequence of any vascular procedure, whether surgical or interventional, the extracellular matrix (ECM), which activates a flow of inflammatory responses, can lead to thrombosis and the formation of scar tissue inside the vessel (neointimal hyperplasia) resulting in re-stenosis/re-narrowing. The current methodology to prevent the formation of scar tissue is to administer antiproliferative drugs during vascular procedures, potentially hindering the healing of the injured ... READ MORE